Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

AIM: Anticoagulation prophylaxis for stroke is recommended for at-risk patients with either persistent or paroxysmal atrial fibrillation (AF). We compared outcomes in patients with persistent vs. paroxysmal AF receiving oral anticoagulation. METHODS AND RESULTS: Patients randomized in the Rivaroxaba...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinberg, Benjamin A., Hellkamp, Anne S., Lokhnygina, Yuliya, Patel, Manesh R., Breithardt, Günter, Hankey, Graeme J., Becker, Richard C., Singer, Daniel E., Halperin, Jonathan L., Hacke, Werner, Nessel, Christopher C., Berkowitz, Scott D., Mahaffey, Kenneth W., Fox, Keith A.A., Califf, Robert M., Piccini, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313363/
https://www.ncbi.nlm.nih.gov/pubmed/25209598
http://dx.doi.org/10.1093/eurheartj/ehu359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313363/
https://www.ncbi.nlm.nih.gov/pubmed/25209598
http://dx.doi.org/10.1093/eurheartj/ehu359

Ejemplares similares